Corporate INTL Newsroom · Topic
Life Sciences & Pharmaceuticals News & Analysis
Pharmaceuticals, biotech and medical products: regulation, product liability, intellectual property and the deals that shape the sector.
Life Sciences & Pharmaceuticals stories
Life Sciences & Pharmaceuticals
COINS Act Biotech: Treasury Proposes Barring US Investment in Chinese Drug Developers
Life Sciences & Pharmaceuticals
Do Medical Devices Need to Be CE Marked? EU MDR Rules, UKCA and Selling in Great Britain
Life Sciences & Pharmaceuticals
Political Agreement Reached on the EU Pharmaceutical Reform Package
Life Sciences & Pharmaceuticals
Most-Favored-Nation Drug Pricing Order Sets 30-Day Targets for Pharma Companies
Life Sciences & Pharmaceuticals
Commission Proposes Critical Medicines Act to Rebuild EU Drug Supply Chains
Life Sciences & Pharmaceuticals
EU HTA Regulation Now Applies: What Joint Clinical Assessments Mean for Drug Developers
Life Sciences & Pharmaceuticals
New UK Clinical Trials Regulations Laid in Parliament After 20 Years
Life Sciences & Pharmaceuticals
Commission Imposes €462.6 Million Teva Fine Over Copaxone Patent Misuse
Life Sciences & Pharmaceuticals
Lecanemab Licensed in Great Britain but NICE Says No to NHS Funding
Life Sciences & Pharmaceuticals
European Parliament Adopts Its Position on EU Pharmaceutical Reform
Life Sciences & Pharmaceuticals
What the European Health Data Space Deal Means for Patients and Researchers
Life Sciences & Pharmaceuticals